Defining a lineage-specific chimerism threshold for the use of donor lymphocyte infusions in treating myeloid malignancies
Bone Marrow Transplant
.
2025 Jan 13.
doi: 10.1038/s41409-025-02510-8.
Online ahead of print.
Authors
Christian J Puzo
1
,
Stuart Seropian
2
,
Henry Rinder
3
,
Christopher A Tormey
3
,
Alexa J Siddon
4
5
Affiliations
1
Yale School of Medicine, New Haven, CT, USA.
2
Department of Hematology, Yale School of Medicine, New Haven, CT, USA.
3
Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA.
4
Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA. Alexa.siddon@yale.edu.
5
Department of Pathology, Yale School of Medicine, New Haven, CT, USA. Alexa.siddon@yale.edu.
PMID:
39806028
DOI:
10.1038/s41409-025-02510-8
No abstract available
Publication types
Letter